Patient Knowledge of Antithyroid Drug-Induced Agranulocytosis

Publisher： Karger

E-ISSN： 2235-0802|3|4|245-251

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.3, Iss.4, 2014-10, pp. : 245-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Periodic Granulocyte Count Measuring Is Useful for Detecting Asymptomatic Agranulocytosis in Antithyroid Drug-Treated Patients with Graves' Disease

By  

European Thyroid Journal, Vol. 5, Iss. 4, 2016-09 ,pp. : 253-260

Karger

Access to resources Recommend Favorite

Genotype and Phenotype Predictors of Relapse of Graves’ Disease after Antithyroid Drug Withdrawal

By  

European Thyroid Journal, Vol. 1, Iss. 4, 2012-10 ,pp. : 251-258

Karger

Access to resources Recommend Favorite

Graves’ Disease in Childhood: Advances in Management with Antithyroid Drug Therapy

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 6, 2009-06 ,pp. : 310-317

Karger

Access to resources Recommend Favorite

Excessive Iodine Intake Does Not Increase the Recurrence Rate of Graves' Disease after Withdrawal of the Antithyroid Drug in an Iodine-Replete Area

By  

European Thyroid Journal, Vol. 4, Iss. 1, 2015-03 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

Breastfeeding and Antithyroid Drugs: A View from Within

By  

European Thyroid Journal, Vol. 1, Iss. 1, 2012-02 ,pp. : 30-33

Karger

Access to resources Recommend Favorite